جست‌وجوی استاد و پژوهشگر

• Exercise Physiology
• Sports Science
• Metabolism
• +۳ مورد دیگر

Cecilie Moe Weinreich serves as an Academic employee and Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. She is affiliated with the Clemmensen Group focusing on exercise and muscle physiology, based at Blegdamsvej 3B, Mærsk Tårnet, 6th floor, Copenhagen. Her research centers on Exercise Physiology , Sports Science , and Metabolic Health , with specific expertise in Aging Research , Obesity Interventions , and Inflammation Mechanisms . She investigates clinical applications of resistance training, polyphenol supplementation, and pharmacological agents like salbutamol in human performance and metabolic outcomes. Recent publications reveal a strong emphasis on sex-specific physiological responses and randomized controlled trials targeting aging populations and obesity. Her work bridges exercise science with clinical gerontology and metabolic disease management, often examining biomarkers of inflammation and cardiorespiratory fitness. She actively collaborates within the Clemmensen Group on projects involving lifestyle interventions, VO2 peak analysis, and endurance training adaptations, contributing to high-impact publications in journals like GeroScience and International Journal of Obesity.

Colin Farrellyمشاهده پروفایل

استاد

• Political Philosophy
• Bioethics
• Practical Ethics
• +۵ مورد دیگر

Colin Farrelly is the Sir Edward Peacock Professor of Political Theory at Queen's University, cross-appointed with the Department of Philosophy and occasionally teaching in the School of Policy Studies. He holds a PhD from the University of Bristol, along with degrees from McMaster University. His research focuses on political philosophy, bioethics, and the ethics of biomedical advancements, particularly in aging and geroscience. Farrelly has held academic positions globally, including at Oxford, UCLA, and Waterloo University. His work integrates normative theory with empirical insights from biology, demography, and medicine, emphasizing the Enlightenment's ideals of reason and progress. Education: B.A. in Political Studies, Philosophy from McMaster University M.A. in Political Studies, Philosophy from McMaster University Ph.D. in Political Theory from the University of Bristol Research Interests: Farrelly's interdisciplinary work spans political theory, bioethics, and the societal implications of longevity science. Key topics include geroscience (healthy aging), climate geroscience, virtue ethics, and justice in genomic contexts. He advocates for 'positive biology' to refocus medical sciences on healthspan extension and critiques 'folkbiology' in public health discourse. Recent Articles: Recent publications address intersections of aging, climate science, and ethical policy. He emphasizes the societal and ethical dimensions of longevity research, arguing for science that prioritizes human well-being over disease-focused paradigms. Labs/Teams: Collaborates with global networks in geroscience and biomedical ethics, though no specific lab is named. His work often involves interdisciplinary teams across philosophy, medicine, and policy.

Patricia Jumbo-Lucioniمشاهده پروفایل

دانشیار

• Metabolic physiology
• mitochondrial biology
• neurodegenerative diseases
• +۳ مورد دیگر

Patricia Jumbo-Lucioni is an Associate Professor at Samford University's McWhorter School of Pharmacy in the Department of Pharmaceutical, Social and Administrative Sciences. She holds an MD from Universidad Peruana Cayetano Heredia and a PhD in Nutrition Sciences from University of Alabama at Birmingham, with postdoctoral training at Emory and Vanderbilt universities. Her research program investigates therapeutic interventions for Alzheimer's disease using Drosophila models. Research integrates mitochondrial physiology, neurodegeneration, and microbiome interactions, with particular focus on ACE inhibitors and gut-brain axis modulation. Recent work examines sex-specific cognitive effects of probiotic therapies and metabolic impacts of pharmacological agents. Publications demonstrate progressive focus on neurodegenerative mechanisms and translational applications: Neuroprotective effects of repurposed cardiovascular drugs Microbiome-targeted interventions for cognitive decline Metabolic dysregulation in Alzheimer's models Honors include teaching excellence awards and competitive research fellowships from professional organizations. Professional affiliations include Alabama Academy of Science, Alzheimer's Association, and American Association of Colleges of Pharmacy. Community engagement includes serving as educator for Alabama Alzheimer's Association chapter.

Marianne Nygaardمشاهده پروفایل

دانشیار

• Genetic Epidemiology
• Aging Research
• Functional Genomics
• +۱۲ مورد دیگر

Marianne Nygaard is an Associate Professor in the Department of Public Health at the University of Southern Denmark, affiliated with the Danish Twin Research Center and the research group for Epidemiology, Biostatistics and Biodemography. She holds an M.Sc. and serves as head of biobank, contributing to major population-based studies on aging and genetics. Her research is centered on genetic epidemiology, aging research, and functional genomics . Key areas include genome-wide association studies (GWAS), DNA methylation, cognitive function, longevity, and the genetic basis of psychiatric and neurodevelopmental traits. She leverages data from twin studies and family-based cohorts to disentangle genetic and environmental influences on health outcomes. The trends in her recent publications reflect a strong focus on genetic and epigenetic mechanisms of aging, cognitive reserve, and longevity . Her work often involves large-scale collaborations, with recent articles appearing in Nature Human Behaviour , Alzheimer's & Dementia , and GeroScience , covering topics such as extreme human longevity, cognitive decline, and gene-environment interactions. Scientific Contributions and Activities: Active peer reviewer for journals including Brain, Behavior, and Immunity Regular participant and speaker at conferences such as the 27th Nordic Congress of Gerontology Member of PhD examination committees Guest lecturer and external educator Research Projects: LLFS: Long Life Family Study (2006–2025): Investigating family-based genetic and environmental factors in longevity Genetic and Epigenetic Influences on Aging and Lifespan : Focused on DNA methylation and CpG sites in aging processes

• Human Ageing
• Genetics of Longevity
• Biomarkers of Ageing
• +۷ مورد دیگر

Joris Deelen is a Research Group Leader at the Max Planck Institute for Biology of Ageing in Cologne, Germany, where he leads research on the genetic and biomarker underpinnings of human longevity. His work bridges molecular epidemiology, functional genomics, and metabolomics to understand why some individuals age more healthily than others. PhD in Molecular Epidemiology, Leiden University (cum laude) MSc and BSc in Biomedical Sciences, Leiden University His research focuses on identifying and functionally characterizing rare genetic variants in long-lived individuals using CRISPR/Cas9 models and large-scale human cohort data. He also investigates metabolic biomarkers predictive of mortality and healthy ageing. His recent work emphasizes integrating multi-omics data to uncover mechanisms of ageing. The trends in his publications reflect a strong focus on human ageing genetics, with key contributions in genome-wide association studies, functional validation of genetic variants, and metabolic profiling for mortality prediction. His work spans high-impact journals such as Nature and Nature Communications , highlighting translational relevance. His scientific awards include: ERC Starting Grant (2022–2027) Longevity Impetus Grant (2022–2026) Humboldt Research Fellowship (2017) Dr. Deelen supervises several PhD students and leads a multidisciplinary team integrating bioinformatics, molecular biology, and clinical data. He has secured major third-party funding and is establishing human ageing studies in Cologne to validate biomarkers in clinical settings. His lab collaborates extensively with international cohorts and leverages data from model organisms. He is actively involved in advancing the biology of ageing through innovative research, aiming to compress morbidity and extend healthspan.

Shabnam Salimiمشاهده پروفایل

استادیار مدعو

• Biomarkers of Chronic Diseases
• Aging Research
• Systems Biology
• +۳ مورد دیگر

Dr. Shabnam Salimi serves as an Adjunct Assistant Professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine. A physician-scientist trained in genetic epidemiology and computational biology, she focuses on biomarkers of chronic diseases and aging processes using omics data integration. Her work bridges clinical medicine with public health applications, particularly in understanding aging mechanisms and chronic disease pathophysiology. Education: MD, Kermanshah University of Medical Sciences (2003) MSc, Umea University (2008) Postdoctoral Fellowship in Genetic Epidemiology, University of Maryland Baltimore (2015) Postdoctoral Fellowship in Epidemiology of Aging, University of Maryland Baltimore (2017) Dr. Salimi's research centers on identifying molecular biomarkers for aging and chronic diseases through advanced omics methodologies. She investigates how genetic, epigenetic, and environmental factors interact to influence aging trajectories and disease susceptibility, with particular emphasis on cardiovascular health, bone metabolism, and inflammatory pathways. Her work leverages large population cohorts including the Old Order Amish and Baltimore Hip Fracture Study to translate findings into clinical and public health applications. Her 15 most recent publications (2017-2020) demonstrate expertise across environmental epidemiology, genetic associations with aging, and pandemic-related aging research. Key themes include air pollution impacts on vascular function, molecular crosstalk between aging hallmarks and infectious diseases, and multi-omics approaches to biomarker discovery in diverse populations. Much of this work involves NHLBI's TOPMed consortium and utilizes whole-genome sequencing in multi-ancestry cohorts. Professional Recognition: National Institute on Drug Abuse Travel Awards (2011, 2014) World Health Organization Travel Award (2011) Radiation Research Society Young Investigator Award (2014) American Heart Association Fellowship (2016) Multiple best presentation awards at aging research conferences (2017-2018) Dr. Salimi has secured pilot funding as Principal Investigator through the University of Maryland Claude D. Pepper Older Americans Independence Center for research on inflammatory markers following hip fracture. Her work has been supported by NIH institutes including NIA, NHLBI, and NIDDK, with additional recognition from the Radiation Research Society and American Heart Association. She actively collaborates with interdisciplinary teams across geriatrics, nephrology, and environmental health research. She contributes to the Geriatrics and Gerontology Education and Research Program and participates in the Aging ShowCase at Johns Hopkins University, working within multidisciplinary teams focused on translational geroscience and aging biomarker development.

Sebiha Çevik KAPLANمشاهده پروفایل

استادیار

• Molecular Genetics
• Cilia Biology
• Reproductive Aging
• +۲ مورد دیگر

Sebiha Çevik KAPLAN serves as an Assistant Professor at Abdullah Gül University in Turkey. Her academic foundation includes: Ph.D. in an unspecified discipline from University College Dublin (UCD), Ireland (2011) Dr. Kaplan's research program leverages the Caenorhabditis elegans model organism to dissect molecular pathways in genetic disorders, identify novel cilia-associated genes, and pioneer pharmacological interventions for age-related reproductive decline. Her interdisciplinary work bridges molecular genetics, cell biology (focusing on ciliary function), translational geroscience, and neuropharmacology, emphasizing mechanistic insights with therapeutic applications.

Lisa Lesniewskiمشاهده پروفایل

دانشیار

• Aging
• Obesity
• Adipose Tissue Biology
• +۸ مورد دیگر

Lisa Lesniewski, Ph.D. , is an Associate Professor of Internal Medicine at the University of Utah School of Medicine and an Adjunct Assistant Professor of Nutrition and Integrative Physiology. She directs an active research program investigating the vascular and metabolic consequences of aging and obesity, with emphasis on adipose tissue biology, arterial dysfunction, and atherosclerosis. Education B.S., Ohio State University Ph.D., Texas A&M University Research Interests Dr. Lesniewski’s laboratory explores how aging and obesity synergistically impair vascular and metabolic health. Central themes include: Adipose tissue as an endocrine organ driving systemic inflammation and metabolic dysfunction. Telomere dysfunction and cellular senescence in adipose and arterial tissues. mTOR signaling and the potential of rapamycin-based interventions to counter vascular aging. MicroRNA networks—especially miR-92a—in arterial growth, aging, and atherosclerosis. The small GTPase ARF6 as a mechanosensitive regulator of endothelial inflammation and atherogenesis. Research Output & Trends Across more than 40 peer-reviewed publications (2019-2024), her group has advanced a translational pipeline from molecular mechanism (DNA damage, telomere uncapping, senolytic therapy) to organismal phenotype (arterial stiffness, glucose intolerance, atheroma burden) in both mouse models and human cohorts. A consistent innovation is the integration of high-resolution imaging biosensors with in-vivo vascular phenotyping to dissect single-cell metabolic heterogeneity within aged and obese tissues. Scientific Awards & Honors No specific awards are listed in the provided materials. Funding & Collaborative Networks Dr. Lesniewski has sustained NIH funding for projects spanning vascular aging, adipose inflammation, and metabolic dysfunction. She actively collaborates with investigators in Molecular Biology, Nutrition and Integrative Physiology, and Cardiovascular Medicine at the University of Utah, as well as with national geroscience consortia. Laboratory & Teams The Lesniewski Laboratory is housed within the University of Utah’s Molecular Medicine Program and has access to core facilities in metabolic phenotyping, advanced microscopy, and small-animal cardiovascular physiology. The team comprises post-doctoral fellows, graduate students, and research technicians working on parallel but integrated projects aimed at translating pre-clinical discoveries into therapeutic strategies for age-related cardiometabolic disease.

• Neuroscience
• Motor function
• Dementia research
• +۷ مورد دیگر

Kaylee Rudd is a Junior Research Fellow at the Wicking Dementia Research Education Centre, University of Tasmania. Her research focuses on exploring motor biomarkers of the early stages of dementia, with particular emphasis on non-invasive and affordable screening tools to detect people at risk of developing dementia. She works within the ISLAND Project and ISLAND Clinic, which aims to create a one-stop interdisciplinary cognitive clinic model that addresses rural health inequality and reduces diagnosis time. Dr. Rudd holds a Bachelor of Medical Research (Honors) from the University of Tasmania, completed between February 2021 and November 2021. Prior to her current role, she served as a Research Assistant at the Wicking Dementia Research and Education Centre (February 2023 - November 2024), Project Officer at the University of Tasmania (January 2022 - November 2022), and Student Success Leader at the University of Tasmania, Hobart (January 2021 - December 2021). Her primary research interests center on the intersection of motor function and cognitive decline, specifically investigating how upper limb motor function, gait analysis, and other movement biomarkers can serve as early indicators of dementia. Dr. Rudd's work particularly focuses on developing and validating digital tools, including smartphone applications, for home-based screening of preclinical Alzheimer's disease and other forms of dementia. Her research spans multiple disciplines including neuroscience, geriatrics, cognitive science, and digital health technologies. Analysis of Dr. Rudd's publication record reveals a strong focus on translating motor biomarker research into practical clinical applications. Her work demonstrates how digital tools measuring hand movement, gait, and other motor functions can detect early cognitive changes before traditional symptoms appear. The progression of her research shows increasing sophistication in combining multiple motor tasks and integrating digital biomarkers with plasma markers to improve diagnostic accuracy across the dementia continuum. Dr. Rudd has secured funding for significant research projects, most notably 'Exploring clinic manifestations of late-onset Essential Tremor: a pre-cognitive biomarker of dementia?' funded by the Royal Hobart Hospital Research Foundation ($24,966; January 2023 - September 2025). She actively mentors PhD and Honours students as part of her role at the University of Tasmania (February 2022 - December 2024). Her scholarly contributions include numerous publications in high-impact journals such as GEROSCIENCE, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, and BMC NEUROLOGY, with her most recent work published in May 2025. Dr. Rudd has presented her research at major conferences including the Alzheimer's Association International Conference and the Australian Dementia Research Forum.

• Fall Prevention
• Musculoskeletal Health
• Cardiovascular Health
• +۳ مورد دیگر

Dr. Marc Sim is a Senior Research Fellow at Edith Cowan University (ECU) within the School of Medical and Health Sciences, leading the Falls Free Future Program under the Nutrition and Health Innovation Research Institute (NHIRI). He also serves as Deputy Lead for the Disorders of Mineralisation Research Group at ECU. His research focuses on reducing falls and fractures in older populations through nutrition, physical activity, and musculoskeletal health. He holds a PhD from The University of Western Australia (2015) and is an accredited Exercise and Sport Scientist and registered Nutritionist. Key research interests include the interplay between cardiovascular and musculoskeletal health, vitamin K’s role in fracture prevention, and sarcopenia management. He leads the Perth Longitudinal Study of Aging Women and collaborates internationally, including with the Royal Perth Hospital Research Foundation. Awards include the 2025 International Osteoporosis Foundation Young Investigator Award and 2023 Young Tall Poppy Science Award. Dr. Sim has secured grants totaling ~$1.1M AUD from Denmark’s Independent Research Fund and Australian health initiatives. His work spans clinical trials, biostatistics, and public health interventions. He advises national organizations like the Australian Bone and Mineral Society and contributes to global consensus efforts on sarcopenia definitions.

Vaibhav Upadhyayمشاهده پروفایل

استادیار

• Gut Microbiome
• Acute Lung Injury
• Pulmonary Medicine
• +۳ مورد دیگر

Vaibhav Upadhyay, MD, PhD is an Assistant Professor in the Department of Medicine at UCSF's School of Medicine. As a physician-scientist, he leads research on gut microbiome impacts on human health with clinical focus in pulmonary medicine. His laboratory investigates microbial influences on acute lung injury and chronic diseases using multi-omic approaches. Education includes: BS in Biochemistry from Duke University (2007) PhD in Immunology from University of Chicago (2013) MD from University of Chicago (2015) Internal Medicine Residency at UCSF (2018) Pulmonary and Critical Care Fellowship at UCSF (2021) Chief Fellowship in Pulmonary and Critical Care at UCSF (2021) Research focuses on gut-lung axis interactions, particularly how gut microbial metabolites influence pulmonary inflammation and injury. His work bridges immunology, microbiome science, and pulmonary medicine to develop novel therapeutic approaches for acute lung injury and interstitial lung diseases. Current projects examine bacterial lactate effects on lung epithelial mitochondria and microbial contributions to drug response variability. Publications consistently explore microbiome-host interactions across disease contexts, with recent emphasis on COVID-19 impacts on microbiota stability, microbial influences on cancer therapy toxicity, and diet-microbiome-immune system crosstalk. Research employs cutting-edge techniques including phage immunoprecipitation sequencing, single-nucleus RNA-seq, and multi-omics integration. Awards and honors: ATS RCMB Abstract Scholarship (2022) Jeffrey Golden Outstanding Clinical Fellow Award (2021) Two Pulmonary Division Clinical Fellow Awards (2019, 2020) UCSF Fellows Leadership Cohort (2020) Alpha Omega Alpha Honor Society (2014) Best Dissertation Award, University of Chicago (2013) Summa Cum Laude, Duke University (2007) Research funding includes an NIH/NHLBI K08 award (2023-2028) studying gut bacterial metabolites in acute lung injury, a Benioff Center grant examining SARS-CoV-2 microbiome interactions, and a CTSI grant exploring autoantigens in interstitial lung disease. Leads a research team collaborating with multiple UCSF laboratories including the Turnbaugh Lab.

Julio Cesar Cardenasمشاهده پروفایل

دانشیار

• Calcium Signaling
• Cancer Metabolism
• Mitochondrial Biology
• +۴ مورد دیگر

Julio Cesar Cardenas is an Associate Professor at the Center for Integrative Biology, Faculty of Sciences, Universidad Mayor in Chile. He concurrently holds adjunct professorships at the Department of Chemistry and Biochemistry, University of California, Santa Barbara (since 2017), and the Buck Institute for Research on Aging, California (since 2016). His research focuses on calcium signaling mediated by the inositol 1,4,5-trisphosphate receptor (InsP3R), particularly its role in cellular bioenergetics, cancer metabolism, and aging. Education: B.Sc. in Medical Technology (2000) and Ph.D. in Biomedical Science (2005), both from Universidad de Chile. Postdoctoral training under Dr. Clara Franzini Armstrong (2006-2007) and Dr. Kevin Foskett (2007-2011) at the University of Pennsylvania. Research Interests: Investigates how ER-mitochondrial calcium communication regulates cellular processes like autophagy, proliferation, and metabolism. Key discoveries include the essential role of InsP3R-mediated calcium signaling in cancer cell bioenergetics and its therapeutic potential in diseases like Parkinson's, Alzheimer's, diabetes, and obesity. Labs: Director of CardenasLab, part of the Geroscience Center for Brain Health and Metabolism. Research emphasizes translational tools to modulate mitochondrial function and extend healthspan.

Derek M. Huffmanمشاهده پروفایل

استاد

• Aging and Metabolism Interaction
• Geriatric Drug Discovery
• Gerontological Approaches to Age-Related Diseases
• +۴ مورد دیگر

Dr. Derek M. Huffman es profesor en los Departamentos de Farmacología Molecular y Medicina (Endocrinología) en el Albert Einstein College of Medicine. Actualmente dirige el Health Span Core y es codirector del Einstein Nathan Shock Center y de la beca NIA T32 en biología del envejecimiento. Es miembro del Einstein Cancer Center y del Einstein-Mt. Sinai Diabetes Research Center. Sus investigaciones se centran en tres áreas clave: (1) la interacción entre el envejecimiento y el metabolismo, (2) el descubrimiento de fármacos geriátricos, y (3) estrategias gerontológicas para enfermedades asociadas a la edad. Su trabajo incluye estudios sobre la señalización de IGF-1, parabiosis heterocrónica, factores circulantes rejuvenecedores, y efectos de la dieta (como nueces) en la salud celular y cognitiva. Ha publicado más de 30 artículos en revistas como Nature Communications , Aging Cell , y Cell Reports , con un enfoque en mecanismos celulares, modelos animales, y aplicaciones clínicas. Como líder académico, Huffman coordina programas de formación y colabora en centros multidisciplinarios. Sus contribuciones incluyen protocolos mejorados para parabiosis en ratones y análisis de senescencia celular en múltiples tejidos.

Anders Olsenمشاهده پروفایل

دانشیار

• Biomedicine
• Neurodegeneration
• Aging
• +۷ مورد دیگر

Anders Olsen is an Associate Professor at the Department of Chemistry and Bioscience, Aalborg University, within the Faculty of Engineering and Science. His research focuses on aging, neurodegeneration, and the use of Caenorhabditis elegans as a model organism to study host-microbiome interactions, probiotics, and genetic mutations linked to neurological disorders. He leads the Neuroboost research group, exploring mechanisms of aging and age-related diseases. Key projects include the Lundbeck Foundation Scholarship, where he supervises research on neurodegenerative pathways. His work contributes to the UN Sustainable Development Goals, particularly in advancing biomedicine and understanding aging processes. Olsen has published over 40 articles, with recent work emphasizing microbiome dynamics, probiotic effects, and molecular mechanisms in neurodegeneration. He actively participates in workshops and conferences, such as the Sino-Danish Center exchange visits and lectures on C. elegans applications in microbiome studies. Media coverage highlights his innovative use of C. elegans to uncover insights into aging and diseases like Alzheimer’s and Parkinson’s. Collaborations span microbiology, genetics, and cell biology, reflecting his interdisciplinary approach to geroscience and biomedical research.

• Aging Biology
• Epigenetics
• Psychiatry
• +۷ مورد دیگر

Albert Higgins-Chen is an Assistant Professor in the Department of Psychiatry at Yale University, with a secondary appointment in Pathology. He leads the Higgins-Chen lab, which focuses on developing aging biomarkers to assess the impact of mental health and treatments on aging. His work integrates computational methods, machine learning, and omics data to study interventions for Alzheimer’s, cardiovascular disease, and cancer. He earned his MD/PhD from the University of Michigan and AB from Harvard. Education: PhD, University of Michigan, Cellular and Molecular Biology (2017) MD, University of Michigan, Cellular and Molecular Biology (2017) AB, Harvard University, Biochemical Sciences (2009) Research: Develops epigenetic clocks and machine learning tools to measure biological aging Investigates interactions between psychiatric disorders (e.g., schizophrenia, depression) and aging biomarkers Leads collaborations in geroscience, translational medicine, and clinical trials Key Projects: Validating aging biomarkers for longevity interventions Studying epigenetic mutations in cancer and cardiovascular aging Integrating mental health with aging biology through biomarker development His lab emphasizes interdisciplinary approaches, combining computational pipelines with clinical and experimental data. Recent work includes resolving technical noise in epigenetic clocks and identifying age-invariant genes in mice. Current projects address how psychiatric treatments affect biomarkers of aging and mortality risk.